Jean-Pierre Provost

Engineer in Biochemistry
CES Animal Clinical Biochemistry and Hematology

Head of Clinical Pathology and endocrinology laboratories at Pfizer, Safety Science Europe Pfizer, Global Research and Development, Amboise, France 

Main activity: management of the technical staff , writing and follow-up of study reports for clinical pathology, implementation of new technologies and biomarkers.

Other activities,  Corporate 

 Other activities, External

PhD,  Engineer in Biochemistry

Join Pfizer Global Research and Development on 1970 at  the  European Pre-Clinical Toxicology Center located at  Amboise,  France.

Responsible for the clinical chemistry laboratory. Main activity : set up and validate  analytical techniques and procedures adapted to laboratory animals. 

Head of clinical biochemistry in the toxicology center of Pfizer Central Research from 1980

Head of clinical pathology and endocrinology  department from 1990.

Member of  the  Immunotoxicity Center of Expertise (ICE) from 2001, in charge to implement the CPMP guidelines at Amboise within the new Pfizer Global Research and Development (PGRD) structure.

Joined Pfizer, Research Center, Amboise in 1969 as responsible for the clinical chemistry laboratory. Main activity: set up and validate analytical techniques and procedures adapted to laboratory animals. 

Head of clinical biochemistry and endocrinology laboratories from 1980. Head of clinical pathology services from 1990.

Other activities ,Internal

Other activities, External

 

Jean-Pierre Provost

Docteur-Ingénieur en Biochimie, CES d’hématologie et de biochimie animale (ENV Toulouse)

Employé au centre européen de Toxicologie pré-clinique de Pfizer, à Amboise, au sein d’une structure internationale  actuellement  appelée  PGRD (Pfizer Global Research and Development).

Activité principale actuelle: Responsable du service de pathologie clinique et d’endocrinologie animale. Depuis 2000, membre du groupe d’harmonisation internationale pour la pathologie clinique. Depuis 2001, représentant l’Europe au sein  du Centre Pfizer d’expertise en immuno-toxicologie chargé de la mise en place des nouvelles réglementations du CPMP.